LATE-BREAKING ABSTRACT: Randomised controlled trial of telemonitoring with addition of daily forced oscillation in older people with COPD and co-morbidity
| Autor: | Valentina Isetta, Ruth Sepper, A Niroshan Siriwardena, Pasquale P. Pompilio, Trine S Bergmo, Andrei Malinovschi, Dorijan Marušiç, Peter M.A. Calverley, Giulia Munaro, Christer Janson, Tanja Grzetic Romcevic, Roberto Rosso, Raffaele Dellaca, Jo Middlemass, Josep M. Montserrat, Kaiu Prikk, Paulo Zanaboni, Paul Walker |
|---|---|
| Rok vydání: | 2016 |
| Předmět: |
COPD
Pediatrics medicine.medical_specialty 020205 medical informatics Exacerbation business.industry 02 engineering and technology medicine.disease law.invention 03 medical and health sciences 0302 clinical medicine Airway resistance Quality of life Randomized controlled trial law Internal medicine 0202 electrical engineering electronic engineering information engineering Medicine 030212 general & internal medicine business Older people Forced oscillation Oxygen saturation (medicine) |
| Zdroj: | 5.2 Monitoring Airway Disease. |
| DOI: | 10.1183/13993003.congress-2016.oa3519 |
| Popis: | Evidence of clinical benefit and cost-effectiveness from daily symptom and simple telemonitoring in COPD is unproven. The CHROMED study explored the effect of telemonitoring in older people with COPD and significant co-morbidity who performed daily forced oscillation measurements via RESMON PRO DIARY to identify early physiological change associated with an exacerbation. Six centres in 5 countries randomised 312 people to 9 months telemonitoring (154) or daily symptom questionnaires (158). Each day the monitored group recorded symptoms, pulse, BP, oxygen saturation and airway resistance and reactance. An alert was generated if results exceeded pre-determined parameters and the participant was contacted by their local clinical centre to consider additional treatment. Baseline characteristics were evenly matched: mean age 71 years, FEV1 1.3L (50% predicted) and SGRQ score 49. 61% of subjects had 2+ exacerbations and 42% had been hospitalised in the previous year. Time to first hospitalisation did not differ albeit the monitoring group had fewer hospitalisations (79 vs 103; p=ns) and days in hospital (329 vs. 650; p=ns). However, subjects hospitalized with an AE COPD in the previous year (n=128) had a lower hospitalisation rate (p |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|